{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T01:27:38Z","timestamp":1794706058373,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.gastha.2026.100901","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:26:47Z","timestamp":1771432007000},"page":"100901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction\u2013Associated Steatotic Liver Disease: A Multicenter Study"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-3045","authenticated-orcid":false,"given":"Asahiro","family":"Morishita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeang","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Seko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Shima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhito","family":"Kawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miwa","family":"Kawanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Notsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Oeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Atsukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Aishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gastha.2026.100901_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"10290","key":"10.1016\/j.gastha.2026.100901_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.gastha.2026.100901_bib3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.gastha.2026.100901_bib4","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.gastha.2026.100901_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"38","author":"Araujo","year":"2018","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.gastha.2026.100901_bib6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2018.12.036","article-title":"Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease","volume":"156","author":"Castera","year":"2019","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.gastha.2026.100901_bib7","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/apt.15626","article-title":"Prevalence of significant hepatic fibrosis using magnetic resonance elastography in a health check-up clinic population","volume":"51","author":"Kang","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.gastha.2026.100901_bib8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/hep.24013","article-title":"Noninvasive assessment of liver fibrosis","volume":"53","author":"Martinez","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.gastha.2026.100901_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","author":"Sumida","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gastha.2026.100901_bib10","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.gastha.2026.100901_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2026.100901_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-12-2","article-title":"Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population","volume":"12","author":"Sumida","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.gastha.2026.100901_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.gastha.2026.100901_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep4.1411","article-title":"Impact of implementing a \"FIB-4 First\" strategy on a pathway for patients with NAFLD referred from primary care","volume":"3","author":"Davyduke","year":"2019","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.gastha.2026.100901_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058360","article-title":"NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD","volume":"8","author":"Demir","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.gastha.2026.100901_bib16","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","article-title":"A serum \"sweet-doughnut\" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis","volume":"3","author":"Kuno","year":"2013","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.gastha.2026.100901_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00535-014-0946-y","article-title":"A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis","volume":"50","author":"Toshima","year":"2015","journal-title":"J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gastha.2026.100901_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/hep4.1080","article-title":"Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis","volume":"1","author":"Kamada","year":"2017","journal-title":"Hepatol Commun"},{"issue":"40","key":"10.1016\/j.gastha.2026.100901_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030489","article-title":"Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: a retrospective single-center study","volume":"101","author":"Park","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.gastha.2026.100901_bib20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/jcm9041119","article-title":"Sequential combination of FIB-4 followed by M2BPGi enhanced diagnostic performance for advanced hepatic fibrosis in an average risk population","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.gastha.2026.100901_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.5009\/gnl230128","article-title":"Proposal of a novel serological algorithm combining FIB-4 and serum M2BPGi for advanced fibrosis in nonalcoholic fatty liver disease","volume":"18","author":"Moon","year":"2024","journal-title":"Gut Liver"},{"issue":"7","key":"10.1016\/j.gastha.2026.100901_bib22","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s00535-024-02100-3","article-title":"Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation","volume":"59","author":"Uojima","year":"2024","journal-title":"J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gastha.2026.100901_bib23","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2026.100901_bib24","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","article-title":"AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis","volume":"7","author":"Loaeza-del-Castillo","year":"2008","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.gastha.2026.100901_bib25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.gastha.2026.100901_bib26","first-page":"449","article-title":"The role of platelets in inflammation","volume":"114","author":"Thomas","year":"2015","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.gastha.2026.100901_bib27","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00535-021-01782-3","article-title":"Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis","volume":"56","author":"Itakura","year":"2021","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.gastha.2026.100901_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.gastha.2026.100901_bib29","first-page":"498","article-title":"Comparative evaluation of APRI, FIB-4, HFS, and NFS: scoring tools for liver fibrosis in a Mexican population with MASLD","volume":"89","author":"Priego-Parra","year":"2024","journal-title":"Rev Gastroenterol Mex (Engl Ed)"},{"issue":"1","key":"10.1016\/j.gastha.2026.100901_bib30","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/s12887-024-05263-3","article-title":"Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"Jin","year":"2024","journal-title":"BMC Pediatr"},{"issue":"1","key":"10.1016\/j.gastha.2026.100901_bib31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00535-019-01626-1","article-title":"Diagnostic accuracy of combined biomarker measurements and vibration-controlled transient elastography (VCTE) for predicting fibrosis stage of non-alcoholic fatty liver disease","volume":"55","author":"Shima","year":"2020","journal-title":"J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gastha.2026.100901_bib32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep4.1386","article-title":"Cost saving or cost effective? Unanswered questions in the screening of patients with nonalcoholic fatty liver disease","volume":"3","author":"Jiang","year":"2019","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.gastha.2026.100901_bib33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.30842","article-title":"Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials","volume":"70","author":"Anstee","year":"2019","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.gastha.2026.100901_bib34","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.21037\/atm-20-5216","article-title":"Clinical implications of serum Mac-2-binding protein glycan isomer as a novel biomarker of advanced hepatic fibrosis in diabetes","volume":"8","author":"Park","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.gastha.2026.100901_bib35","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2016.06.027","article-title":"Serum levels of Mac-2 binding protein increase with cardiovascular risk and reflect silent atherosclerosis","volume":"251","author":"Sugiura","year":"2016","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.gastha.2026.100901_bib36","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s00535-023-02043-1","article-title":"New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease","volume":"58","author":"Uojima","year":"2023","journal-title":"J Gastroenterol"},{"issue":"8","key":"10.1016\/j.gastha.2026.100901_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gastha.2026.100901_bib38","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/jgh.13708","article-title":"Hepatic stellate cells secreting WFA(+) -M2BP: its role in biological interactions with Kupffer cells","volume":"32","author":"Bekki","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.gastha.2026.100901_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00535-017-1425-z","article-title":"Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis","volume":"53","author":"Shirabe","year":"2018","journal-title":"J Gastroenterol"},{"issue":"10","key":"10.1016\/j.gastha.2026.100901_bib40","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/hepr.13648","article-title":"Hepatic stellate cell as a Mac-2-binding protein-producing cell in patients with liver fibrosis","volume":"51","author":"Gantumur","year":"2021","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.gastha.2026.100901_bib41","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/hep.32204","article-title":"Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis","volume":"75","author":"Sanyal","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.gastha.2026.100901_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572326000221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:46:10Z","timestamp":1793403970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572326000221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2772572326000221"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100901","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction\u2013Associated Steatotic Liver Disease: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2026.100901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.","name":"copyright","label":"Copyright"}],"article-number":"100901"}}